| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/IJC.24656 |
| P8608 | Fatcat ID | release_4huxtpmu4zhbjju7z67un5wykq |
| P698 | PubMed publication ID | 19530254 |
| P5875 | ResearchGate publication ID | 26295560 |
| P50 | author | Fernando Aranda | Q28317121 |
| Jesús Prieto | Q28324697 | ||
| Pablo Sarobe | Q39790261 | ||
| Juan José Lasarte | Q40687778 | ||
| Pedro Berraondo | Q88084891 | ||
| Noelia Casares | Q93038508 | ||
| Javier Dotor | Q117233004 | ||
| Francisco Borrás-Cuesta | Q117233005 | ||
| Diana Llopiz | Q117283721 | ||
| Nancy Díaz-Valdés | Q117283734 | ||
| Jaione Bezunartea | Q117283735 | ||
| P2093 | author name string | Marta Ruiz | |
| P2860 | cites work | Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells | Q24658240 |
| Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells | Q27860460 | ||
| Subsets of myeloid-derived suppressor cells in tumor-bearing mice | Q29614297 | ||
| Transforming growth factor-beta : biology and clinical relevance | Q36044800 | ||
| In vitro and in vivo down-regulation of regulatory T cell activity with a peptide inhibitor of TGF-beta1. | Q39970343 | ||
| Tumor evasion of the immune system by converting CD4+CD25- T cells into CD4+CD25+ T regulatory cells: role of tumor-derived TGF-beta | Q40168787 | ||
| Introduction of soluble protein into the class I pathway of antigen processing and presentation | Q46305448 | ||
| Cutting Edge: TGF- Signaling Is Required for the In Vivo Expansion and Immunosuppressive Capacity of Regulatory CD4+CD25+ T Cells | Q58131166 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | immunotherapy | Q1427096 |
| P304 | page(s) | 2614-2623 | |
| P577 | publication date | 2009-12-01 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | Peptide inhibitors of transforming growth factor-beta enhance the efficacy of antitumor immunotherapy | |
| P478 | volume | 125 |
| Q37293334 | A mathematical model of the enhancement of tumor vaccine efficacy by immunotherapy |
| Q30580198 | Combining antibody-directed presentation of IL-15 and 4-1BBL in a trifunctional fusion protein for cancer immunotherapy. |
| Q43035679 | Enhanced T cell responses against hepatitis C virus by ex vivo targeting of adenoviral particles to dendritic cells |
| Q44327591 | Epithelial to mesenchymal transition and cancer stem cell phenotypes leading to liver metastasis are abrogated by the novel TGFβ1-targeting peptides P17 and P144. |
| Q27002646 | Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy |
| Q28390399 | Immunological effects of the TGFβ-blocking antibody GC1008 in malignant pleural mesothelioma patients |
| Q91045407 | Increased type III TGF-β receptor shedding decreases tumorigenesis through induction of epithelial-to-mesenchymal transition |
| Q33858506 | Intratumoral Lentivector-Mediated TGF-β1 Gene Downregulation As a Potent Strategy for Enhancing the Antitumor Effect of Therapy Composed of Cyclophosphamide and Dendritic Cells |
| Q49379553 | Microenvironment‑driven resistance to B‑Raf inhibition in a melanoma patient is accompanied by broad changes of gene methylation and expression in distal fibroblasts |
| Q38821941 | Myeloid-derived suppressor cells: The green light for myeloma immune escape. |
| Q37019136 | Myeloid-derived suppressor cells: natural regulators for transplant tolerance |
| Q38896948 | Overexpression of apolipoprotein A-I fused to an anti-transforming growth factor beta peptide modulates the tumorigenicity and immunogenicity of mouse colon cancer cells |
| Q38978526 | Quantitative method for in vitro matrigel invasiveness measurement through image analysis software. |
| Q38172210 | Searching for the Achilles Heel of FOXP3 |
| Q41010363 | Targeting TGF-β Mediated SMAD Signaling for the Prevention of Fibrosis |
| Q89241989 | Targeting TGFβ Signaling to Address Fibrosis Using Antisense Oligonucleotides |
| Q36462348 | Targeting the TGFβ signalling pathway in disease |
| Q39202332 | The Process and Regulatory Components of Inflammation in Brain Oncogenesis |
| Q37454364 | The polarization of immune cells in the tumour environment by TGFbeta |
| Q38357137 | The role of oncolytic virus immunotherapies to subvert cancer immune evasion |
| Q47149854 | Therapeutic strategies against cancer stem cells in human colorectal cancer |
| Q58754397 | Transforming Growth Factor-β-Induced Cell Plasticity in Liver Fibrosis and Hepatocarcinogenesis |
| Q50104779 | Transforming growth factor-β in stem cells and tissue homeostasis |
| Q37918451 | Transforming growth factor-β signaling in tumor initiation, progression and therapy in breast cancer: an update |
| Q41916350 | Tumor initiating cells and chemoresistance: which is the best strategy to target colon cancer stem cells? |
| Q36747346 | Using macrophage activation to augment immunotherapy of established tumours |
Search more.